SCANDMEDICAL SOLDK (Germany) Performance
| K41 Stock | 0.81 0.02 2.41% |
The firm owns a Beta (Systematic Risk) of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SCANDMEDICAL SOLDK's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCANDMEDICAL SOLDK is expected to be smaller as well. At this point, SCANDMEDICAL SOLDK 040 has a negative expected return of -0.1%. Please make sure to validate SCANDMEDICAL SOLDK's mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if SCANDMEDICAL SOLDK 040 performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
SCANDMEDICAL |
SCANDMEDICAL SOLDK Relative Risk vs. Return Landscape
If you would invest 89.00 in SCANDMEDICAL SOLDK 040 on August 30, 2024 and sell it today you would lose (8.00) from holding SCANDMEDICAL SOLDK 040 or give up 8.99% of portfolio value over 90 days. SCANDMEDICAL SOLDK 040 is currently producing negative expected returns and takes up 2.8978% volatility of returns over 90 trading days. Put another way, 25% of traded stocks are less volatile than SCANDMEDICAL, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SCANDMEDICAL SOLDK Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCANDMEDICAL SOLDK's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCANDMEDICAL SOLDK 040, and traders can use it to determine the average amount a SCANDMEDICAL SOLDK's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0358
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | K41 |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SCANDMEDICAL SOLDK is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCANDMEDICAL SOLDK by adding SCANDMEDICAL SOLDK to a well-diversified portfolio.
About SCANDMEDICAL SOLDK Performance
By analyzing SCANDMEDICAL SOLDK's fundamental ratios, stakeholders can gain valuable insights into SCANDMEDICAL SOLDK's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCANDMEDICAL SOLDK has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCANDMEDICAL SOLDK has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about SCANDMEDICAL SOLDK 040 performance evaluation
Checking the ongoing alerts about SCANDMEDICAL SOLDK for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCANDMEDICAL SOLDK 040 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SCANDMEDICAL SOLDK generated a negative expected return over the last 90 days | |
| SCANDMEDICAL SOLDK has some characteristics of a very speculative penny stock |
- Analyzing SCANDMEDICAL SOLDK's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCANDMEDICAL SOLDK's stock is overvalued or undervalued compared to its peers.
- Examining SCANDMEDICAL SOLDK's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SCANDMEDICAL SOLDK's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCANDMEDICAL SOLDK's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SCANDMEDICAL SOLDK's stock. These opinions can provide insight into SCANDMEDICAL SOLDK's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SCANDMEDICAL Stock analysis
When running SCANDMEDICAL SOLDK's price analysis, check to measure SCANDMEDICAL SOLDK's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDMEDICAL SOLDK is operating at the current time. Most of SCANDMEDICAL SOLDK's value examination focuses on studying past and present price action to predict the probability of SCANDMEDICAL SOLDK's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDMEDICAL SOLDK's price. Additionally, you may evaluate how the addition of SCANDMEDICAL SOLDK to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |